Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope

Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope

Abstract To relieve the limitations of the human papillomavirus (HPV) vaccines based on L1 capsid protein, vaccine formulations based on RG1 epitope of HPV L2 using various built-in adjuvants are under study. Herein, we describe design and construction of a rejoined peptide (RP) harboring HPV16 RG1...

Full description

Bibliographic Details
Main Authors: Maryam Mashhadi Abolghasem Shirazi, Seyed Mehdi Sadat, Setareh Haghighat, Farzin Roohvand, Arash Arashkia
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-43965-3

Internet

https://doi.org/10.1038/s41598-023-43965-3

Similar Items